Episode 82
Biotech Hangout
00:00
The Importance of Cash in the Biotech Industry
The chapter discusses the significance of cash and its relevance to biotech companies. It explores how investors often overlook the value of cash when considering stock purchases and potential dilution after positive data catalysts. The speakers also touch on the examples of Amgen and Gilead as the only companies returning cash to shareholders through dividends.
Transcript
Play full episode
